All OTC and prescription drugs containing paracetamol sold in France will from 2020 be required to carry prominent on-pack warnings about the potential for misuse to cause liver damage.
France’s national medicines agency, ANSM, has given manufacturers of the more than 200 paracetamol-based drugs available in the country until April 2020 to modify the packaging of their
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?